The median duration and the median dosage of CBD exposure were 6.8 months and 4.3mg/kg/day, respectively. Eighty-five percent of all parents reported a reduction in seizure frequency, and 14% reported complete seizure freedom. A high proportion of respondents reported improvement in sleep (53%), alertness (71%), and mood (63%) during CBD therapy. Researchers note: From a methodological standpoint, this study is extraordinarily vulnerable to participation bias and limited by lack of blinded outcome ascertainment. Appropriately controlled clinical trials are essential to establish efficacy and safety.
Likely probability of the efficacy of cannabis for treatment of Epilepsy according to the results found in this study.
Likely probability of the efficacy of cannabis for treatment of Lennox-Gastaut syndrome (LGS) according to the results found in this study.
CBD-enriched cannabis preparations